[16] [17] These factors create confounding variables when attempting to isolate medication-specific risk from underlying patient characteristics
[2] However, findings suggest that the majority of individuals that start a GLP-1 do not take the medication for the recommended 12 weeks, suggesting they are not achieving clinically meaningful weight loss.[2] Currently, 1 in 8 American adults have used one of the GLP-1 drugs and at least 30% ceased before 4 weeks, likely due to gastrointestinal distress.[2] Additionally, it is reported that there were over 25,000 emergency room visits between 2022-2023 due to GLP-1 use
in rare cases, irregular heart rhythms, dizziness, fainting or collapse especially in people with pre-existing heart or electrolyte problems
Microdosing GLP-1 Cons User reports reveal three consistent problems
Comparison Table Compare GLP-1 medications to find the best fit for your injection routine